Nathaniel E. David

2017

In 2017, Nathaniel E. David earned a total compensation of $2.6M as President at Unity Biotechnology.

Compensation breakdown

Non-Equity Incentive Plan$169,575
Option Awards$1,973,679
Salary$425,000
Total$2,568,254

David received $2M in option awards, accounting for 77% of the total pay in 2017.

David also received $169.6K in non-equity incentive plan and $425K in salary.

Rankings

In 2017, Nathaniel E. David's compensation ranked 4,314th out of 14,666 executives tracked by ExecPay. In other words, David earned more than 70.6% of executives.

ClassificationRankingPercentile
All
4,314
out of 14,666
71st
Division
Manufacturing
1,512
out of 5,772
74th
Major group
Chemicals And Allied Products
435
out of 2,075
79th
Industry group
Drugs
333
out of 1,731
81st
Industry
Pharmaceutical Preparations
263
out of 1,333
80th
Source: SEC filing on April 26, 2019.

David's colleagues

We found one more compensation record of an executive who worked with Nathaniel E. David at Unity Biotechnology in 2017.

2017

Keith Leonard

Unity Biotechnology

Chief Executive Officer

News

In-depth

You may also like